insights_auto
Bakit bumaba ang BOT 5.88%?
Tingnan ang Higit pang Detalyechevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.016
arrow_downward
-5.88%(-0.0010) 1D
Okt 8, 12:53:23 PM GMT+11 · AUD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa BOT...
Buksan
A$0.02
Mataas
A$0.02
Mababa
A$0.02
Mkt. cap
37.47M
Avg. na dami
5.92M
Dami
754.60K
Mataas nang 52-wk
A$0.17
Mababa nang 52-wk
A$0.02
EPS
-A$0.03
Mga natitirang share
2.76B
Bilang ng mga empleyado
11
Buksan
A$0.02
Mataas
A$0.02
Mababa
A$0.02
Mkt. cap
37.47M
Avg. na dami
5.92M
Dami
754.60K
Mataas nang 52-wk
A$0.17
Mababa nang 52-wk
A$0.02
EPS
-A$0.03
Mga natitirang share
2.76B
Bilang ng mga empleyado
11
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Quartz
·
12 oras ang nakalipas
Dow drops 451 points as Treasury yields hit 24-year highs
investingLive
·
13 oras ang nakalipas
The S&P 500 reached a new record high, but the gains are vulnerable to a sharp reversal
Investor's Business Daily
·
1 buwan ang nakalipas
Dow Jones Futures: Techs Set To Run? Nvidia, CrowdStrike, Okta, Salesforce Jump On Earnings
Reuters
·
1 buwan ang nakalipas
S&P 500 to end 2026 slightly above current levels on profit optimism
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Tungkol sa Botanix Pharmaceuticals Ltd